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Postoperative Pain Management Following Outpatient Anterior Cruciate Ligament Reconstruction – A 1 
Systematic Review of Randomized Controlled Trials  2 
Abstract 3 
Background: 4 
Effective pain management following anterior cruciate ligament reconstruction improves patient 5 
satisfaction and function. 6 
Purpose: 7 
We collected and evaluated the available evidence from randomized controlled trials on postoperative 8 
pain control following anterior cruciate ligament reconstruction. 9 
Study Design: 10 
Systematic review. Level 1 and 2. 11 
Methods: 12 
A systematic literature review was performed using PubMed, Medline, Google Scholar, UpToDate, 13 
CINAHL and Scopus following PRISMA guidelines (July 2014). Only randomized control trials comparing a 14 
method of postoperative pain control to another method or placebo were included.  15 
Results: 16 
Seventy seven randomized controlled trials met inclusion criteria, 14 on regional nerve blocks, 21 on 17 
intraarticular injections, 4 on intramuscular/intravenous injections, 12 on multimodal regimens, 6 on oral 18 
medications, 10 on cryotherapy/compression, 6 on mobilization and 5 on intraoperative techniques.  19 
Single injection femoral nerves block provided superior analgesia to placebo for up to 24 hours 20 
postoperatively, however this also resulted in a quadriceps motor deficit. Indwelling femoral catheters 21 
utilized for 2 days postoperatively provided superior analgesia to a single injection femoral nerve block. 22 
Local anesthetic injections at the surgical wound site or intraarticularly provided equivalent analgesia to 23 
regional nerve block. Continuous infusion catheters of local anesthetic provide adequate pain relief, but 24 
have been shown to cause chondrolysis. 25 
Cryotherapy improved analgesia compared to no cryotherapy in 4 trials, while in 4 trials ice water and 26 
room temperature water provided equivalent analgesic effects. Early weightbearing decreased pain 27 
compared to delayed weightbearing. 28 
Preoperative gabapentin and zolpidem for the first week postoperatively each decreased opioid 29 
consumption compared to placebo. Ibuprofen reduced pain compared to acetaminophen. Oral ketorolac 30 
reduced pain compared to hydrocodone-acetaminophen.  31 
Conclusion: 32 
Regional nerve blocks and intraarticular injections are both effective forms of analgesia. Cryotherapy-33 
compression appears beneficial provided IA temperatures are sufficiently decreased. Early mobilization 34 
reduces pain symptoms. Gabapentin, zolpidem, ketorolac and ibuprofen decrease opioid consumption. 35 
Despite the vast amount of high quality evidence on this topic, however, further research is needed to 36 
determine the optimal multimodal approach that can maximize recovery while minimizing pain and 37 
opioid consumption. 38 
Clinical Relevance: 39 
These results provide the best available evidence from randomized controlled trials on pain control 40 
regimens for anterior cruciate ligament reconstruction. 41 
 42 
 43 
  44 
Main Text 45 
Introduction 46 
The anterior cruciate ligament (ACL) is the most commonly reconstructed ligament in the knee. 73 In 2006 47 
129,836 ACL reconstructions were performed in the United States, and the annual rate is increasing. 74 48 
Effective postoperative pain management is a critical component to recovery, effective rehabilitation and 49 
patient satisfaction. Following ACL reconstruction, psychological factors are predictive of outcomes, 36 50 
and pain levels are inversely associated with function 19 and quality of life assessments. 40 51 
The two main measures used to quantify patient pain symptoms are postoperative opioid medication 52 
consumption and pain scales.  Commonly used pain scales include the visual analog scale (VAS), verbal 53 
rating scale (VRS) and the numeric rating scale (NRS).  Although these methods rely on patient reporting 54 
of subjective feelings, they are highly reproducible and reliable. 7, 8 55 
There is an abundance of literature evaluating various postoperative pain management medications and 56 
modalities following ACL reconstruction. Individual systematic reviews have analyzed the efficacy of 57 
cryotherapy, 76 femoral nerve blocks (FNB), 75 continuous passive motion (CPM), 105 and postoperative 58 
rehabilitation. 68 We performed a systematic review of all level I and level II randomized controlled trials 59 
and present a comprehensive review of the evidence surrounding postoperative pain management for 60 
outpatient arthroscopic ACL reconstruction.  61 
Methods 62 
A comprehensive literature review was performed to identify all randomized controlled trials (RCTs) on 63 
postoperative pain management following ACL reconstruction. Searches for the terms “anterior cruciate 64 
ligament” and “postoperative pain” were performed using the search engines PubMed, Medline, Google 65 
Scholar, UpToDate, Cochrane Reviews, CINAHL and Scopus (from inception to July 2014). Additional 66 
searches for multimodal analgesia, continuous passive motion, immobilization, early weightbearing, 67 
cryotherapy, compression, intraarticular injection, nerve block, NSAIDs, hydrocodone, acetaminophen, 68 
and opiates were also conducted in the same databases along with the term “anterior cruciate ligament.” 69 
Reference sections of relevant articles were reviewed in an attempt to identify further relevant trials. 70 
Inclusion criteria were studies that were randomized control trials, level I or II, that compared any two or 71 
more pain management modalities to other modalities or placebo, utilizing objective measures to 72 
quantify post-operative pain within the first postoperative month. Only modalities that can be applied to 73 
postoperative pain management after ACL reconstruction in the outpatient setting were included. 74 
Notation was made of the surgical methodology used in each study and this can be found in the 75 
supplemental tables. All methods of arthroscopic reconstruction were included. Studies which performed 76 
co-procedures such as meniscus or articular cartilage surgery alongside ACL reconstruction were 77 
included. Intravenous (IV) morphine was considered valid as a pain metric but not as a treatment because 78 
of our desire to evaluate “outpatient” treatment approaches. Exclusion criteria were as follows: non 79 
English language or non-human articles, nonrandomized trials, studies which included patients 80 
undergoing other surgical interventions alongside patients undergoing ACL reconstruction, open ACL 81 
reconstruction, meta-analyses or systematic reviews of randomized controlled trials, retracted papers or 82 
papers published by first authors associated with multiple cases of academic fraud, and studies which did 83 
not measure pain symptoms. Data was collected including demographic information, pain outcomes and 84 
complications for each included study. Wherever applicable, statistically significant results are reported. 85 
PRISMA criteria were followed throughout the study. Quality appraisal was also performed for each 86 
individual trial. 87 
Results 88 
A total of 77 RCTs met inclusion criteria for this systematic review. A PRISMA flow diagram of the 89 
literature search and included studies can be found in Figure 1.  Of the 77 included studies, 14 were trials 90 
of regional nerve blocks, 21 were trials of intraarticular (IA) injections, 4 were trials of intramuscular (IM) 91 
or intravenous (IV) injections, 12 compared differing analgesic regimens, 6 were trials on oral 92 
medications, 10 were trials of cryotherapy or compression, 6 were trials of differing postoperative 93 
mobilization strategies and 5 were trials of intraoperative techniques. One trial consisted of two separate 94 
phases, which are presented here as individual trials. A concise summary of all interventions, which 95 
resulted in a statistically significant decrease in either reported pain symptoms or opioid consumption, 96 
can be found in tables 1-8. Additional information regarding each RCT including graft types, number of 97 
subjects, dosages, pain metrics, rescue medications, p-values, as well as pain and medication values for 98 
each comparison group can be found in tables 1-8 of the supplemental section. Complications reported in 99 
association with each intervention analyzed in this systematic review are included in table 9. The costs of 100 
each medication and the Medicare fee schedule for preoperative injections are included in table 10. 101 
Regional Nerve Blocks (Table 2): 102 
Femoral nerve block: 103 
When compared to a saline injection, a single injection femoral nerve block (FNB) significantly decreased 104 
VAS scores up to 60 minutes postoperatively 93 in one trial, up to the night of surgery in another, 44 and up 105 
to 24 hours in a third. 48 A single injection FNB also significantly decreased postoperative morphine 106 
consumption compared to saline injection. 44, 93 In a group of patients blinded to receiving a saline or 107 
bupivacaine FNB injection, a supplemental bupivacaine FNB injection was offered with a reported VAS 108 
score greater than 4. Significantly more patients in the saline group elected to receive the supplemental 109 
FNB, with 50% of patients in the saline group doing so within 40 minutes of the completion of surgery. 87 110 
Because the femoral nerve innervates the quadriceps, femoral nerve block resulted in a motor deficit in 111 
all of these studies, 44, 48, 93 which persisted for the same amount of time as the analgesic effect. 87 112 
Other regional nerve blocks: 113 
The addition of a sciatic nerve block to a FNB yielded significantly decreased analgesic consumption and 114 
NRS scores at first analgesia request compared to FNB alone. 58 As compared to a standard FNB there 115 
were no significant differences in pain scores or postoperative narcotic consumption between groups 116 
receiving a fascia iliaca nerve block 38 or a subsartorial saphenous nerve block. 18 The percentage of 117 
patients requiring intraoperative analgesic supplementation was significantly lower when a posterior 118 
psoas compartment block was used as compared to an anterior 3-in-1 FNB (femoral, obturator and lateral 119 
femoral cutaneous nerves). 17 120 
Patients receiving a bupivacaine bolus followed by a continuous saline infusion through a FNB catheter 121 
had significantly reduced NRS pain scores and oxycodone consumption through postoperative day one as 122 
compared to patients receiving placebo (saline bolus, saline infusion). Moreover, patients receiving a 123 
bupivacaine bolus followed by continuous bupivacaine infusion had significantly lower NRS scores on 124 
postoperative days 1, 2 and 4 and significantly lower oxycodone consumption on day 2 as compared to 125 
placebo. 119 The addition of a continuous infusion of bupivacaine provided through a FNB catheter to a 126 
patient controlled analgesia (PCA) device that dispensed bupivacaine boluses resulted in significantly 127 
lower NRS scores compared to PCA boluses alone. 108 128 
Stimulating catheters for nerve block placement: 129 
FNB provided through a stimulating catheter led to significantly faster onset of anesthesia and 130 
significantly lower postoperative ketorolac consumption compared to FNB performed using a 131 
nonstimulating catheter. 29  132 
Dosages of nerve blocks: 133 
A comparison of 0.0625 % bupivacaine, 0.125% bupivacaine, and 0.25 % bupivacaine for a continuous 134 
infusion FNB at 0.12 mg/kg/hour, resulted in no significant differences in VAS scores or morphine 135 
consumption at any timepoint. 110 No significant differences were found in VAS scores up to 24 hours 136 
when comparing a single injection FNB using 0.25 % bupivacaine, 0.20 % ropivacaine, or 0.75 % 137 
ropivacaine. 121  138 
Additions of other drugs to nerve blocks: 139 
The addition of clonidine to a femoral-sciatic nerve block did not significantly decrease VAS scores or 140 
analgesic consumption compared to femoral-sciatic nerve block alone. 23 141 
Intraarticular Injections (Table 3): 142 
Intraarticular bupivacaine: 143 
An IA bupivacaine injection significantly decreased VAS scores compared to an IA saline injection up to 4 144 
hours postoperatively 62 but not on the night of surgery. 63 A preoperative local and IA infiltration of 145 
bupivacaine significantly decreased VAS scores on the night of surgery but did not significantly decrease 146 
piritramid (synthetic opiod analgesic available in certain European countries) consumption as compared 147 
to placebo (saline). 52 Continuous IA bupivacaine infusion significantly reduced median VAS scores 2 and 148 
narcotic consumption at 48-72 hours 92 as compared to no infusion. In two of three trials continuous IA 149 
bupivacaine infusion significantly reduced pain scores and rescue medication consumption compared to 150 
continuous IA saline infusion. 2, 51, 92 The addition of preoperative and postoperative bupivacaine 151 
infiltrations at incision sites significantly decreased analgesic consumption as compared to a single 152 
postoperative IA bupivacaine injection. 16 153 
Intraarticular Morphine injections: 154 
IA morphine significantly decreased VAS scores and analgesic consumption compared to IA saline 155 
injection 4, 12, 47, 59, 62, 106, 122 and IA methadone injection. 4, 106 A dose-dependent response was reported 156 
when IA injections of 5 mg, 10 mg, and 15 mg of morphine were compared, 122 but not when 1 mg and 3 157 
mg were compared. 111  A continuous 48 hour IA infusion of morphine and ropivacaine did not 158 
significantly decrease VAS scores compared to IA saline infusion. 116 The addition of an IA morphine 159 
injection to a 3 in 1 FNB did not significantly decrease morphine consumption or VAS scores compared to 160 
the 3 in 1 FNB alone. 80 161 
Combination bupivacaine-morphine intraarticular injections: 162 
An IA bupivacaine-morphine injection significantly decreased VAS scores and analgesic consumption as 163 
compared to IA saline, 45, 111 IA morphine alone, 111 and IA bupivacaine alone. 103, 111 One study showed no 164 
significant difference in VAS scores and analgesic consumption between IA bupivacaine-morphine and IA 165 
bupivacaine injections. 45  IA morphine-bupivacaine injections provided after tourniquet release 166 
significantly decreased VAS scores 30 minutes after tourniquet release and analgesic consumption in the 167 
first 30 minutes postoperatively compared to the same injection before tourniquet release but there 168 
were no significant differences beyond these timepoints. 46 169 
Other intraarticular injections 170 
There were no significant differences in any measure between IA methadone and IA saline. 4, 106 IA 171 
tenoxicam (a non-steroidal anti-inflammatory drug (NSAID) indicated for the short-term treatment of 172 
musculoskeletal injury) significantly decreased VAS scores and supplementation of pethidine (an opioid 173 
analgesic marketed under the generic name demerol which the American Pain Society does not 174 
recommend for use as an analgesic 1) compared to IA saline injections. 47 IA tenoxicam resulted in 175 
significantly fewer patients requiring pethidine than IA morphine. 47 The addition of IA sufentanil (a 176 
fentanyl analog) to an IA ropivacaine/clonidine injection significantly decreased rescue analgesia 177 
requirement during the first postoperative hour compared to IA ropivacaine/clonidine alone but did not 178 
significantly decrease VAS scores at any timepoint. 3 The injection of a multidrug cocktail consisting of 179 
ropivacaine, morphine, ketorolac and cefuroxime either periarticularly, or both intraarticularly and 180 
periarticularly significantly decreased VAS scores in the first 24 hours compared to patients receiving no 181 
injection, IA ropivacaine injection, or IA injection of the same multidrug cocktail. 63 182 
Intravenous or intramuscular Injections (Table 4) 183 
Rescue medication protocols: 184 
There were no significant differences in VAS scores between patients receiving a standard inpatient 185 
rescue medication protocol of IV morphine provided through a PCA device and patients receiving IM 186 
ketorolac injection supplemented by oral (PO) oxycodone. The morphine group had a significantly higher 187 
incidence of postoperative nausea and vomiting as well as urinary retention. 94 188 
Various drugs injected intravenously/intramuscularly: 189 
Patients receiving a postoperative 3.0 μg/kg IV fentanyl injection had significantly lower VRS scores 190 
between 4 and 24 hours following surgery compared to patients receiving 1.5 μg/kg IV fentanyl both 191 
preoperatively and postoperatively. 72 Intraoperative use of IV ketamine infusions significantly decreased 192 
morphine consumption, but not VAS scores, as compared to an IV saline infusion. 85 IV ketorolac injection 193 
significantly decreased both VAS scores and morphine consumption during the first postoperative hour 194 
compared to IV saline injection. 93 195 
Comparative analgesic regimens (Table 5): 196 
A single-injection bupivacaine FNB did not significantly decrease VAS scores compared to a single IA 197 
bupivacaine injection. 82 A single injection ropivacaine FNB significantly decreased VAS scores and total 198 
morphine consumption compared to an IA ropivacaine injection. 56 A single injection preoperative FNB 199 
did not significantly decrease VAS scores or analgesic consumption as compared to postoperative wound 200 
site infiltration. 67 There was no significant difference in VAS scores between a preoperative IA 201 
fentanyl/bupivacaine injection and a 3 in 1 FNB, however a 3 in 1 FNB significantly decreased VAS scores 202 
as compared to the same IA injection administered postoperatively. 78 A femoral-sciatic nerve block 203 
resulted in significantly lower VAS scores and morphine consumption as compared to an IA injection (5 204 
mg morphine, clonidine and bupivacaine). 114 A continuous infusion FNB resulted in no significant 205 
difference in pain scores but significantly less breakthrough pain as compared to patients receiving an IA 206 
injection (10 mg morphine, ropivacaine, epinephrine). 120 207 
A continuous infusion femoral-sciatic nerve block significantly decreased VAS scores and 208 
morphine/ketorolac bolus administration as compared to a continuous bupivacaine IA and patellar 209 
tendon wound site infusion. 28 The addition of either single-injection or continuous FNB to an IA 210 
bupivacaine injection provided no significant decreases in pain scores or analgesic consumption 211 
compared to IA bupivacaine injection alone. 77, 89, 102 The addition of a local bupivacaine infiltration at the 212 
hamstring donor site to single injection FNB resulted in significantly decreased VAS scores up to 8 hours 213 
postoperatively compared to FNB alone. 15 A combination of ketorolac IV, IA ropivacaine-morphine and 214 
FNB administered prior to skin incision resulted in significantly lower VRS scores for the first 2 hours 215 
postoperatively and decreased IV PCA morphine consumption as compared to the same regimen 216 
administered after skin closure. 98 217 
Oral Medications (Table 6) 218 
The administration of 800 mg ibuprofen or a combination of 800 mg ibuprofen and 1 g acetaminophen 1 219 
hour prior to surgery, and at 6 and 12 hours post-surgery resulted in significantly lower VAS scores and 220 
ketobemidone (an opioid analgesic indicated for the treatment of severe pain) consumption as compared 221 
to 1 g acetaminophen alone. The addition of 1 g acetaminophen to 800 mg ibuprofen was no better than 222 
800 mg ibuprofen alone. 26 Patients receiving 30 mg ketorolac had significantly better total pain relief at 3 223 
hours as compared to patients receiving 20 mg hydrocodone combined with 2 g acetaminophen. 5 224 
Patients receiving dexamethasone and parecoxib/etoricoxib/valdecoxib (selective COX-2 inhibitor NSAIDs) 225 
had significantly lower VAS scores during rest at 24 hours and consumed less morphine compared to 226 
patients receiving only parecoxib/etoricoxib/valdecoxib or only dexamethasone. 25 Patients receiving 227 
etoricoxib reported significantly lower VAS scores up to 8 hours postoperatively compared patients 228 
receiving celecoxib or placebo. There were no significant differences in postoperative fentanyl 229 
consumption. 11 230 
The use of 1200 mg gabapentin preoperatively resulted in significantly lower VAS scores during the first 231 
postoperative hour compared to placebo and less morphine consumption at all timepoints measured up 232 
to 36 hours. No adverse events were reported. 84 The use of 10 mg zolpidem (a non-hypnotic sleep aid) 233 
for the first 7 nights postoperatively resulted in significantly lower Vicodin consumption as compared to 234 
placebo, however there was no difference in VAS scores. No adverse events were reported. 112 The costs 235 
of these medications can be found in table 10. 236 
Cryotherapy/Compression (Table 7) 237 
Nine RCTs have analyzed the effects of noncompressive cryotherapy in ACL reconstruction, with 5 238 
reporting decreased pain symptoms and 4 reporting no significant differences as compared to controls. 239 
Postoperative cryotherapy consisting of a continuous flow cryotherapy device or a CryoCuff device 240 
significantly decreased VAS scores and analgesic consumption when compared to no cryotherapy or a 241 
single ice pack in the recovery room. 6, 13  In another trial a continuous flow device significantly reduced 242 
analgesic consumption as compared to no cryotherapy. 22 Preoperative use of cryotherapy significantly 243 
decreased percocet use on the day of surgery and VAS scores up to the morning of the first postoperative 244 
day. 65 In 4 trials there were no significant differences in analgesic consumption or VAS scores between 245 
cryocuff devices, ice packs, or continuous flow cooling pads with cold water or room temperature water. 246 
27, 30, 35, 64 In the only study measuring IA temperatures, a cryotherapy device that maintained IA 247 
temperatures 10 ° C below body temperature resulted in lower VAS scores than no cryotherapy or a 5 ° C 248 
decrease. A 10 ° C decrease in IA temperatures also decreased diclofenac consumption as compared to 249 
controls. No significant differences were observed between a 5 ° C decrease in IA temperatures and 250 
controls. 91 No study reported any adverse events associated with the use of cryotherapy. 251 
A combined cryotherapy-compression device resulted in a significantly higher percentage of patients 252 
discontinuing narcotics 6 weeks postoperatively and a significantly greater decrease in VAS scores from 253 
preoperative levels at 2 and 6 weeks postoperatively compared to ice packs alone. 117 254 
Mobilization Strategies (Table 8) 255 
Immobilization with a plaster cast for 5 weeks postoperatively did not significantly decrease the 256 
proportion of patients reporting pain on the Lysholm score as compared to a hinged brace with range of 257 
motion exercises beginning on postoperative day 7. 49 There were no significant differences in VAS scores 258 
between an unhinged immobilizing brace for two weeks postoperatively and no immobilization.  50 259 
Immediate postoperative weightbearing significantly decreased the proportion of patients reporting pain 260 
symptoms two weeks postoperatively as compared to delaying weightbearing for two weeks 261 
postoperatively, and did not lead to an increase in joint laxity. 115 262 
Continuous passive motion (CPM) device usage for 16 hours per day immediately following surgery 263 
significantly decreased analgesic consumption but not VAS scores compared to controls not using CPM. 79, 264 
123  A continuous active motion (CAM) device, in which the patient used their contralateral leg to pedal 265 
the injured leg, significantly improved proprioception but did not decrease VAS scores as compared to a 266 
CPM device. 43 There were no significant differences in analgesic consumption between patients using 267 
physical therapy, CPM devices or both within the first month postoperatively. 100  268 
Surgical Technique (Table 8) 269 
Patients receiving a postoperative drain reported significantly higher VAS scores in one trial, 31 270 
significantly lower VAS scores in another, 61 and no significant differences in VAS scores or analgesic 271 
consumption in a third 81 when compared to no drain. All 3 studies reported no complications associated 272 
with the use of the drains. 31, 61, 81 Intraoperative tourniquet inflation did not significantly increase 273 
morphine consumption or VRS scores as compared to no tourniquet, although it did improve 274 
intraoperative visibility. 53 275 
Intraoperative use of OMS103HP (an investigational drug product consisting of 13.75 mg ketoprofen, 4.52 276 
mg amitriptyline, and 4.28 mg oxymetazoline added to a 3 L bag of irrigation solution which is used for 277 
arthroscopic irrigation) significantly increased the percentage of patients with satisfactory pain control 278 
(defined as VAS scores less than 20/100 and consuming a maximum of 2 hydrocodone/acetaminophen 279 
tablets per day within the first postoperative week) as compared to standard irrigation solution. There 280 
was no increase in the incidence of adverse events associated with OMS103HP use. 37 281 
Quality Analysis 282 
In many cases the nature of the interventions being studied limited the feasibility of blinding, however 52 283 
of the trials used some form of blinding. Of these, 44 had blinded patients, 42 were double blinded, and 8 284 
were triple blinded. An additional 8 trials did not have blinded patients but did have blinded assessors. 285 
Graft type can influence initial post-operative pain symptoms because of harvest site pain. 42 There were 286 
37 trials which used BPTB autografts exclusively and 19 which used hamstring autografts. Ten trials did 287 
not list the graft type used during reconstruction, and 11 used multiple grafts within the same trial. Eight 288 
of the trials which used more than one graft type included patients who received cadaveric allografts. 289 
Allograft reconstructions do not involve graft harvest morbidity and pain and typically result in less initial 290 
postoperative pain than autografts. 66 This represents a significant possible source of bias in these trials. 291 
The pain scales used here (VAS, NRS, VRS) differed only in whether patients were asked to rate their pain 292 
by marking on a continuous scale or selecting a number out of a given range. There was, however, 293 
significant heterogeneity in the number of timepoints that these pain scale scores were reported. There 294 
was also variability in the nature of these timepoints as some studies reported pain scores based on the 295 
number of hours since the conclusion of surgery while others reported pain scores at milestones such as 296 
entry into the recovery room, first analgesia request, waking the morning following surgery or discharge. 297 
The time of day that surgery is conducted (morning/afternoon/evening) means that the amount of 298 
elapsed time when these milestones occur will differ greatly, introducing possible bias in these studies. In 299 
a RCT on cancer-related breakthrough pain a decrease of 2 points on a 0-10 VAS scale led patients to 300 
forego rescue opioids. 39 This provides objective data for the use of a 2-point decrease as criteria for a 301 
clinically significant result, however the definition of clinical relevance varied significantly between these 302 
trials. 303 
Sixty-three trials reported postoperative medication consumption using 18 different medications. In 11 304 
trials it was unclear what medication was used. Morphine was the most common drug used (27 trials) 305 
however this represents only 42 % of the trials measuring postoperative medication consumption. This 306 
introduces variability into these results and makes comparison of rescue medication consumption 307 
between studies difficult. 308 
Discussion 309 
ACL reconstruction is now almost solely performed on an outpatient basis. While this has been beneficial 310 
in terms of patient satisfaction 69 and costs, 60 it has also complicated postoperative pain management. 311 
Effective pain management in outpatient ACL reconstruction is essential because pain levels are closely 312 
linked to both functional recovery 19 and quality of life assessments. 40 Currently there is no consensus 313 
regarding the optimal management of pain in this setting. Therefore we undertook this study to review 314 
the evidence regarding postoperative pain management following ACL reconstruction. 315 
Previous systematic reviews have analyzed the efficacy of 4 of the interventions discussed here for pain 316 
management following outpatient ACL reconstruction. A meta-analysis of RCTs analyzing cryotherapy use 317 
found that it decreased pain (P = .02) but did not improve knee range of motion. 95 A systematic review of 318 
CPM concluded that it was unclear whether or not it provided any benefit. 105 A systematic review of 319 
postoperative rehabilitation methods concluded that immobilization provided no benefit and there were 320 
no detrimental effects of accelerated rehabilitation. 68 A systematic review of FNB reported that single 321 
injection FNB resulted in statistically significantly reduced pain in 5/13 trials, but the authors questioned 322 
whether or not these decreases were clinically significant. They concluded that single injection FNB did 323 
not decrease pain. 75 This systematic review, however, included studies where IA bupivacaine injections 324 
were given to both the treatment group receiving FNB and the control group receiving no FNB. 325 
Combining IA bupivacaine injection and FNB does not provide a synergistic analgesic effect. 77, 89, 102 FNB 326 
performed in the absence of IA bupivacaine injection, however, reduces pain symptoms for up to 24 327 
hours. 44, 48, 87, 93 The authors of the previous systematic review emphasized that FNB did not decrease 328 
pain beyond 24 hours, but pain scores are highest immediately following surgery and decrease with time. 329 
57 This makes the day of surgery a crucial period for effective pain relief. We believe this justifies the 330 
inclusion of FNB as a component of a multimodal approach to postoperative analgesia in this setting, 331 
particularly if no IA injection is used. 332 
Single injection nerve blocks have consistently been shown to provide superior analgesia to placebo for 333 
up to 24 hours. 44, 48, 87, 93 While this is not long enough to provide effective pain management for the 334 
duration of the acute recovery phase (typically 48-72 hours), pain scores are highest on the day of 335 
surgery. 52 The main risk of FNB is falls, as all FNB dosages block motor output to the quadriceps. 110, 121 In 336 
one study, 1.6 % of patients who received FNB suffered a fall, 104 however, subsartorial saphenous nerve 337 
block provided equivalent analgesia without blocking motor output. 18 This may provide a feasible 338 
alternative to the traditional FNB, and we are currently investigating this. Rarer complications associated 339 
with FNB include vascular puncture, 71 femoral neuritis, 104 and persistent paresthesia. 71 Stimulating 340 
catheters improve the accuracy of injections at the femoral nerve 29 and reduce the risk of these 341 
complications. Continuous infusion bupivacaine pumps prolong the effect of regional nerve blocks. 119 342 
This prolongs the quadriceps strength deficit, necessitating effective patient education and fall prevention 343 
protocols. 344 
Anesthetic injections provided at either the surgical wound site or intraarticularly provide effective 345 
analgesia 16, 52 which is equivalent to FNB. 82 When IA injections are utilized, we add fentanyl to the 346 
injections because IA opioid injections significantly reduce postoperative pain, 4, 12, 47, 59, 62, 106, 122 are less 347 
chondrotoxic than both bupivacaine and ropivacaine, 54 and are not associated with significantly 348 
increased side effects as compared to placebo. 124 While much of the evidence presented here analyzed 349 
the use of IA morphine, we use fentanyl because our decision to incorporate IA opioids into our practice 350 
was based on an RCT analyzing IA fentanyl use in arthroscopy patients. 86 351 
Continuous infusion bupivacaine pumps prolong the effect of IA injections. 2, 51, 92 However, Noyes et al. 352 
reported a case series of 21 patients with disabling knee symptoms due to severe postoperative 353 
chondrolysis secondary to IA bupivacaine pumps 88 and in vitro analysis revealed that 95 % of human 354 
articular chondrocytes undergo apoptosis after 30 minutes of exposure to 0.5% bupivacaine. 21 We do not 355 
use continuous IA bupivacaine infusions in our practice because of this risk. Only continuous infusions of 356 
IA ropivicaine or bupivacaine have been shown to lead to chondrolysis in vivo, 118 however, and 357 
ropivacaine is less chondrotoxic than bupivacaine in vitro. 54 This is why some physicians in our practice 358 
utilize single IA ropivacaine injections. 359 
In our practice we utilize either a preoperative single-injection FNB provided through a stimulating 360 
catheter or an IA ropivacaine-fentanyl injection. We do not use both FNB and IA injections, because 361 
combining IA bupivacaine injection and FNB does not result in a synergistic effect on pain symptoms. 77, 89, 362 
102  We do not commonly use continuous infusion FNB because of the associated fall risk, 104 but are 363 
exploring the use of subsartorial saphenous nerve continuous infusion blocks, because saphenous nerve 364 
blocks do not block quadriceps motor output 18 and continuous infusion nerve blocks can provide longer 365 
postoperative analgesia as compared with single injection regional blocks. 119 366 
Cryotherapy provided effective analgesia compared to controls receiving no cryotherapy 6, 13, 22, 65 in 4 367 
trials, but in 3 trials ice water provided no improvement in pain symptoms compared to room 368 
temperature water. 27, 35, 64 In one study, a 10 ° C decrease below core body temperature provides an 369 
analgesic effect following ACL reconstruction, while a 5 ° C decrease below core body temperature does 370 
not. 91 As none of the other trials studying cryotherapy measured IA temperature, the failure to achieve 371 
the required decrease in IA temperature may provide an explanation for the conflicting results regarding 372 
the efficacy of cryotherapy in these studies. This makes it difficult to determine whether or not this 373 
intervention is beneficial in ACL reconstruction. Combined compression-cryotherapy devices provided 374 
superior analgesia 101, 117 as compared to ice packs alone. We offer cryotherapy-compression devices to 375 
our patients, however insurance does not cover the cost of these devices, leading to a $150 out of pocket 376 
cost to patients who choose to utilize them. This limits the wide applicability of this treatment in our 377 
practice. 378 
We encourage our patients to begin moving their knees early after surgery and to engage in early, 379 
aggressive physical therapy because immediate weightbearing decreases pain without affecting stability. 380 
115  Immobilization does not decrease pain symptoms and can lead to muscular atrophy, impeding the 381 
recovery of function. 49, 50 CPM device usage may have some benefits, 79, 123 however early aggressive 382 
physical therapy provided equivalent results 100 and it cost one group $22,200 annually to rent 10 of these 383 
devices in 2014. 10 The combination of high costs and lack of strong evidence demonstrating decreased 384 
pain symptoms with their use make it difficult to recommend CPM devices in this setting.  We do not 385 
utilize them in our practice for these reasons. 386 
One of the main goals of pain control in the outpatient setting is to minimize the nausea, vomiting, 387 
sedation, respiratory depression and pruritus associated with opioids 97 by providing safer alternatives. 388 
NSAIDs provide a safer, lower risk alternative to opioids for pain medication, with oral ibuprofen providing 389 
greater pain control than acetaminophen 26 and oral ketorolac providing greater pain control than a 390 
combination of hydrocodone and acetaminophen. 5 There is, however, evidence from animal and in vitro 391 
studies linking NSAIDs to detrimental effects on bone, ligament and tendon healing. 107 One retrospective 392 
analysis linked ketorolac to an increase in anterior-posterior knee laxity following BPTB autograft ACL 393 
reconstruction. 83 Although the risk of impaired healing warrants further investigation, we view NSAIDs as 394 
a safe, low cost alternative to oral opioids and prescribe them to our patients for the first 5 days 395 
postoperatively. Gabapentin 84 and zolpidem 112 are additional oral medications that can be beneficial in 396 
reducing opioid consumption postoperatively.  Gabapentin, however, can cause drowsiness and dizziness, 397 
99 and zolpidem can cause nightmares and hallucinations. 113 The associated risk profiles of these 398 
medications limit their use in our practice. The risk profiles and complications of these and other 399 
interventions analyzed in this study can be found in table 9. 400 
Cost analysis is extremely challenging with respect to postoperative pain management after ACL 401 
reconstruction and this study was not intended to provide a true cost analysis, however we have provided 402 
the costs of common medications used in table 10. The specific costs, dosages utilized and combinations 403 
vary from institution to institution. It should be noted that IA injections do not incur an anesthesiologist 404 
fee, while regional nerve blocks/catheters do. These non-facility fees, as determined from the 2013 405 
Medicare physician fee schedule, are also listed in table 10. 406 
This study has several strengths.  It is the first comprehensive systematic review to evaluate all methods 407 
of post-operative pain control following ACL reconstruction.  Only Level I and Level II randomized 408 
controlled trials were included, comprising the best available evidence on the topic.  In addition, the 409 
results have been tabulated for the reader to compare different regimens available for outpatient ACL 410 
reconstruction. 411 
This study is limited mainly by the quality of the studies included and heterogeneity of regimens used.  412 
We restricted our study to randomized control trials to limit any effects of bias and confounding. Many of 413 
the studies discussed here were based upon small patient pools, and therefore could be subject to type 2 414 
errors. Additionally, wide variations in the timing of pain scale scores and postoperative rescue 415 
medications made comparisons of multiple results difficult. Because of the heterogeneity in 416 
measurement techniques and the wide breadth of interventions studied, a combination of data in the 417 
form of a meta-analysis was not attempted. 418 
In accordance with this evidence reviewed in this systematic review, our current multimodal approach to 419 
pain control involves a preoperative single injection femoral nerve block or intraarticular 420 
ropivacaine/fentanyl injection, intraoperative tourniquet use, NSAIDs for the first 5 days postoperatively, 421 
cryotherapy/compression (optional due to associated cost), early weightbearing, early aggressive physical 422 
therapy, and oral percocet as needed. However, there is little evidence regarding the optimal utilization 423 
of evidence-supported modalities in this setting and additional research is needed to compare differing 424 
multimodal regimens.  425 
Conclusions 426 
This study presents and evaluates the currently available randomized, controlled studies on postoperative 427 
pain management after ACL surgery. Nerve blocks and intraarticular injections are both effective forms of 428 
analgesia. Cryotherapy appears to be beneficial provided IA temperatures are sufficiently decreased, and 429 
is most effective when employed in conjunction with compression. Early mobilization reduces pain 430 
symptoms. Several oral medications, namely gabapentin, zolpidem, ketorolac and ibuprofen, provide 431 
effective, reliable alternatives to opioids. Despite the vast amount of high quality evidence on this topic, 432 
however, no consensus exists on the ideal regimen. Further research is needed to determine the optimal 433 
multimodal approach that can maximize recovery while minimizing pain and opioid consumption.  434 
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  770 
Table 1: Significant results of RCTs analyzing pain outcomes following regional nerve block in ACL 771 
reconstruction 772 
Mulroy et al., Harris et al., 
Frost et al., Peng et al. 44, 48, 87, 
93 
Femoral nerve block superior to saline injection or no injection 
Jansen et al. 58 Femoral-sciatic nerve block superior to femoral nerve block 
Cappelleri et al. 17 Posterior psoas approach to 3-in-1 femoral nerve block superior to 
anterior approach to 3-in-1 femoral nerve block 
Williams et al. 119 Continuous infusion femoral nerve block superior to single injection 
femoral nerve block  
Svediene et al. 108 Basal FNB bupivacaine infusion with on-demand boluses superior to 
on-demand boluses alone 
Dauri et al. 29 Femoral nerve block from stimulating catheter superior to femoral 
nerve block from nonstimulating catheter 
 773 
Any intervention resulting in a statistically significant decrease in subjective pain scores or pain 774 
medication consumption is included in this table. Additional information regarding these trials can be 775 
found in table 1 of the supplemental section.  776 
Table 2 – Significant results of RCTs analyzing pain outcomes for intraarticular injections in ACL 777 
reconstruction 778 
Karlsson et al. 62 Intraarticular bupivacaine injection superior to intraarticular saline 
injection 
Guler et al., Arti et al., Stewart 
et al., Brandsson et al., Joshi et 
al., Yari et al., Karlsson et al. 4, 
12, 47, 59, 62, 106, 122  
Intraarticular morphine injection superior to intraarticular saline 
injection 
Tetzlaff et al., Yari et al. 111, 122 Intraarticular injection of morphine and bupivacaine superior to 
intraarticular bupivacaine injection 
Arti et al., Stewart et al. 4, 106 Intraarticular morphine injection superior to intraarticular 
methadone injection 
Yari et al. 122 Intraarticular injection of bupivacaine and 15 mg morphine superior 
to intraarticular injection of bupivacaine and 5 mg morphine 
Vintar et al. 116 Patient controlled analgesia device dispensing intraarticular 
ropivacaine-morphine-ketorolac infusion superior to patient 
controlled analgesia device dispensing intraarticular saline infusion 
Butterfield et al. 16 Preoperative and postoperative bupivacaine infiltrations and 
intraarticular bupivacaine injection superior to intraarticular 
bupivacaine injection 
Parker et al., Alford et al. 2, 92 Continuous intraarticular bupivacaine infusion superior to no infusion 
in 1 of 2 trials 
Parker et al., Hoenecke et al., 
Alford et al.2, 51, 92 
Continuous intraarticular bupivacaine infusion superior to continuous 
intraarticular saline infusion in 2 of 3 trials 
Guler et al. 47 Intraarticular tenoxicam injection superior to intraarticular morphine 
injection 
Armellin et al. 3 Intraarticular injection of ropivacaine, clonidine and sufentanil 
superior to intraarticular injection of ropivacaine and clonidine 
Koh et al. 63 Periarticular or periarticular/intraarticular injection of ropivacaine, 
morphine, ketorolac and cerufoxime superior to intraarticular 
injection of ropivacaine, morphine, ketorolac and cerufoxime  
 779 
Any intervention resulting in a statistically significant decrease in subjective pain scores or pain 780 
medication consumption is included in this table. Additional information regarding these trials can be 781 
found in table 2 of the supplemental section.  782 
Table 3 – Significant results of RCTs analyzing pain outcomes following intramuscular/Intravenous 783 
injections in ACL reconstruction  784 
Menigaux et al. 85 Intravenous ketamine superior to intravenous saline 
Peng et al. 93 Intravenous ketorolac superior to intravenous saline 
Lenz et al. 72 Postoperative 3.0 μg/kg intravenous fentanyl injection superior to 1.5 
μg/kg intravenous fentanyl injection both preoperatively and 
postoperatively 
 785 
Any intervention resulting in a statistically significant decrease in subjective pain scores or pain 786 
medication consumption is included in this table. Additional information regarding these trials can be 787 
found in table 3 of the supplemental section.  788 
Table 4 – Significant results of RCTs analyzing pain outcomes of differing analgesia regimens in ACL 789 
reconstruction  790 
Mehdi et al., Iskandar et al. 56, 
82  
Single injection femoral nerve block superior to single intraarticular 
bupivacaine injection in 1 of 2 trials 
Dauri et al. 28 Continuous infusion femoral nerve block superior to continuous 
intraarticular and wound site bupivacaine infiltration 
Tran et al. 114 Femoral-sciatic nerve block superior to intraarticular injection of 
bupivacaine + 5 mg morphine 
Mayr et al. 78 3-in-1 femoral nerve block superior to postoperative intraarticular 
fentanyl-bupivacaine injection 
Woods et al. 120 Continuous infusion FNB superior to intraarticular injection of 
bupivacaine and 10 mg morphine with available oxycodone tablets 
Bushnell et al. 15 Femoral nerve block with hamstring autograft donor site bupivacaine 
infiltration superior to femoral nerve block alone 
Rosaeg et al. 98 Preoperative intravenous ketorolac, intraarticular ropivacaine-
morphine injection and femoral nerve block superior to the same 
multimodal regimen employed postoperatively 
 791 
Any intervention resulting in a statistically significant decrease in subjective pain scores or pain 792 
medication consumption is included in this table. Additional information regarding these trials can be 793 
found in table 4 of the supplemental section.  794 
Table 5 – Significant results of RCTs analyzing pain outcomes following oral medications for ACL 795 
reconstruction 796 
Dahl et al.  26 Oral ibuprofen superior to oral acetaminophen 
Barber et al. 5 Oral ketorolac superior to oral hydrocodone and acetaminophen 
Dahl et al. 25 Oral dexamethasone and parecoxib/etoricoxib/valdecoxib superior to 
oral dexamethasone/parecoxib/etoricoxib/valdecoxib 
Boonriong et al. 11 Oral eteroicoxib superior to oral celecoxib or placebo 
Menigaux et al. 84 Oral gabapentin superior to oral placebo 
Tompkins et al. 112 Oral zolpidem superior to oral placebo 
 797 
Any intervention resulting in a statistically significant decrease in subjective pain scores or pain 798 
medication consumption is included in this table. Additional information regarding these trials can be 799 
found in table 5 of the supplemental section.  800 
Table 6 – Significant results of RCTs analyzing pain outcomes for cryotherapy and compression in ACL 801 
reconstruction 802 
Barber et al., Brandsson et al., 
Cohn et al., Daniel et al., 
Dervin et al., Edwards et al., 
Konrath et al., Koyonos et al. 6, 
13, 22, 27, 30, 35, 64, 65 
Cryotherapy superior to no cryotherapy or room temperature water 
in 4 of 8 trials 
Waterman et al. 117 Cryotherapy and compression superior to cryotherapy alone 
Ohkoshi et al. 91 10 ° C intraarticular decrease below body temperature superior to 5 ° 
C intraarticular decrease below body temperature or no cryotherapy  
 803 
Any intervention resulting in a statistically significant decrease in subjective pain scores or pain 804 
medication consumption is included in this table. Additional information regarding these trials can be 805 
found in table 6 of the supplemental section.  806 
Table 7 – Significant results of RCTs analyzing pain outcomes with differing mobilization strategies for ACL 807 
reconstruction 808 
Tyler et al. 115 Immediate postoperative weightbearing superior to delayed 
postoperative weightbearing 
Mccarthy et al., Yates et al. 79, 
123  
Continuous passive motion device use superior to no continuous 
passive motion 
 809 
Any intervention resulting in a statistically significant decrease in subjective pain scores or pain 810 
medication consumption is included in this table. Additional information regarding these trials can be 811 
found in table 7 of the supplemental section.  812 
Table 8 – Significant results of RCTs analyzing pain outcomes following differing intraoperative techniques 813 
for ACL reconstruction  814 
Dhawan et al., Karahan et al., 
Mccormack et al. 31, 61, 81 
 
Postoperative drain insertion superior to no drain in 1 of 3 trials 
Fanton et al. 37 Arthroscopic irrigation solution containing experimental drug 
OMS103HP superior to standard irrigation solution 
 815 
Any intervention resulting in a statistically significant decrease in subjective pain scores or pain 816 
medication consumption is included in this table. Additional information regarding these trials can be 817 
found in table 8 of the supplemental section. 818 
  819 
Table 9 – Possible complications associated with interventions used for pain control following ACL 820 
reconstruction 821 
Intervention Complications 
Single injection femoral nerve 
block 
Decreased quadriceps motor function and fall risk, 97 vascular 
puncture, 71 persistent paresthesia 71  
Continuous infusion femoral nerve 
block 
Bacterial catheter colonization, 24 permanent nerve injury 55 
Continuous intraarticular 
bupivacaine infusion 
Chondrolysis leading to articular cartilage degeneration 88 
Bupivacaine/Ropivacaine Cardiac arrest, 32 seizure, 41 
Ketamine Sedation, sleep pattern change, dizziness, depersonalization, 
hallucinations 20 
Opioids Dependency, nausea, vomiting, sedation, respiratory 
depression, pruritus 97 
NSAIDs Gastrointestinal bleeding, 70 decreased bone, ligament and 
tendon healing 107 
COX-2 Inhibitors Thrombosis 9 
Acetaminophen Hepatotoxicity 14 
Gabapentin Drowsiness, dizziness, ataxia and confusion 99 
Zolpidem Nightmares, hallucinations 113 
Cryotherapy Nerve palsy 33 
CPM device Increased wound drainage and wound complications 90 
Intraarticular drain Increased need for transfusion, 96 bacterial colonization 34 
Tourniquet Venous thromboembolic events 109 
 822 
Complications for each intervention are based on a literature review and do not reflect the results of the 823 
individual randomized controlled trials presented in this systematic review. 824 
  825 
Table 10 – Costs associated with medications used for pain control following ACL reconstruction 826 
Medication* Unit Dose  Cost/Fee 
Injectable   
Bupivacaine pf 0.5% 10 ml vial  $    1.21  
Bupivacine pf 0.5% 30 ml vial  $    1.30  
Ropivacaine pf 0.5% 30 ml vial  $    6.35  
Morphine 2 mg  1 ml carpuject  $    1.77  
ketorolac 30 mg 1 ml vial  $    1.79  
Epinephrine 1/100000 1 ml ampule  $    1.27  
Fentanyl 50 mcg/ml 2 ml vial  $    1.00  
Ketamine 50 mg/ml  10 ml vial  $    2.70  
Dexamethasone 4mg 1 ml vial  $    0.68  
PCA   
Fentanyl 10 mcg/ml 55 ml syringe  $  12.20  
Hydromorphone 0.2 mg/ml 50 ml syringe  $  11.90  
Oral    
Hydrocodone  2 mg tablet  $    0.16  
Ibuprofen 200 mg tablet  $    0.30  
Acetaminophen 325 mg tablet  $    0.02  
Celecoxib  200 mg tablet  $  1.95  
Zolpidem 5 mg tablet  $    0.04  
Injections    
Single sciatic nerve injection  $139.15 
Continuous sciatic nerve 
infusion 
 $78.59 
Single femoral nerve 
injection 
 $121.46 




*Medication costs acquired from large tertiary care hospital pharmacy.  828 
 Non-facility fees acquired from 2013 Medicare physician fee schedule – national average. 829 
  830 
Figure 1 – Literature review results according to PRISMA criteria 831 
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